Editor’s note: This story has been corrected to state that Castellum Inc — not Constellium SE — announced the pricing of a public stock offering.
With U....
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please ...
With U.S. stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows:
Constellium SE CSTM announc...
SAN DIEGO, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment a
Shares of Marvell Technology, Inc. MRVL rose sharply in today's pre-market trading after the company reported better-than-expected third-quarter financial resul...
This week, once again, companies across the biotech sector continued to re-evaluate their pipelines and trim their workforces in a bid to conserve cash and extend their financial runway.
XOMA is entitled to a mid-single digit royalty on global OJEMDA™ sales First and only FDA-approved type II RAF inhibitor for patients with relapsed or...
Shares of Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the company reported fourth-quarter financial results and issued weak Q1 guidance.
WAVE Life Sciences Ltd. (WVE), a preclinical biopharmaceutical company, has seen a significant increase in its stock price over the past three months. The compa
/PRNewswire/ -- The HDAC (histone deacetylase) Inhibitors Market by Route of Administration, Distribution Channel, and Geography - Forecast and Analysis...
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
To be held on November 17, 2022
Dear Shareholder:
We cordially invite you to attend the Annual... | October 5, 2022
Human Papillomavirus Associated Cancer Pipeline constitutes 50+ key companies continuously working towards developing 50+ Human Papillomavirus Associated...